40 years disease mechanism research, 20 years biotech drug development experience

Opinion leader in Epigenetics, 146 peer-reviewed publications

$16 M in Federal and Foundation Grant support, Bill and Melinda Gates funded Investigator

$11.3 M raised as investor capital for OyaGen, Inc

Designed and established 7 laboratories since 1976 and directed operations at SUNY at Buffalo, Baylor College of Medicine, URMC Rochester, OyaGen, Inc and CannaMetrix, LLC